```html

Zollinger‑Ellison Syndrome Gastro‑Pain

What is Zollinger‑Ellison syndrome gastro‑pain?

Zollinger‑Ellison syndrome (ZES) is a rare disorder in which one or more gastrin‑producing neuroendocrine tumors (called gastrinomas) develop in the pancreas or duodenum. These tumors secrete excessive amounts of gastrin, a hormone that stimulates the stomach lining to produce large volumes of acid. The resulting hyper‑acidic environment irritates the duodenum and jejunum, leading to persistent or recurrent gastro‑pain—often described as burning, gnawing, or cramping pain that may be worse after meals or at night.

Although ZES accounts for less than 1 % of all ulcers, the pain can be severe and is frequently accompanied by ulceration in the small intestine, which is atypical for ordinary peptic ulcer disease. Early recognition of the pain pattern is crucial because untreated ZES can cause bleeding, perforation, and malabsorption.

Sources: Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); WHO.

Common Causes

While ZES itself is caused by gastrin‑secreting tumors, the gastro‑pain experienced by patients can be exacerbated or mimicked by several other conditions. Understanding these helps clinicians rule out alternative diagnoses.

• Gastrinomas (primary cause) – Usually located in the duodenum (≈70 %) or pancreas.
• Multiple Endocrine Neoplasia type 1 (MEN 1) – A hereditary syndrome that includes gastrinomas, parathyroid, and pituitary tumors.
• Peptic ulcer disease (PUD) – Ulcers caused by Helicobacter pylori or NSAID use can produce similar pain.
• Duodenal ulcer perforation – Leads to sudden, severe abdominal pain.
• Gastro‑esophageal reflux disease (GERD) – Acid reflux can mimic burning gastro‑pain.
• Pancreatitis – Inflammation of the pancreas often presents with epigastric pain radiating to the back.
• Helicobacter pylori infection – Increases gastric acid secretion and ulcer risk.
• Non‑steroidal anti‑inflammatory drug (NSAID) use – Directly damages the gastric mucosa.
• Small‑bowel tumors (e.g., carcinoid) – Can cause ulceration and pain.
• Functional dyspepsia – A disorder of gut–brain interaction that causes chronic upper‑abdominal discomfort.

Associated Symptoms

Because the excess acid attacks more of the gastrointestinal tract than in typical ulcer disease, ZES often produces a constellation of symptoms beyond pain:

• Recurrent or chronic ulcers in the duodenum, jejunum, or even the colon.
• Frequent heartburn or acid reflux.
• Diarrhea (often watery), sometimes with steatorrhea due to fat malabsorption.
• Unexplained weight loss despite normal or increased appetite.
• Nausea and vomiting, especially after meals.
• Signs of **gastric‑intestinal bleeding** – melena, hematemesis, or iron‑deficiency anemia.
• Fatigue and weakness secondary to anemia or chronic malnutrition.
• Occasional abdominal bloating or a feeling of fullness.

When ZES is part of MEN 1, patients may also have hyperparathyroidism (causing kidney stones) or pituitary adenomas (headaches, vision changes).

Sources: Cleveland Clinic; NIH; American College of Gastroenterology (ACG) guidelines.

When to See a Doctor

Because ZES is rare but potentially serious, prompt medical evaluation is recommended if any of the following occur:

• Severe or progressively worsening epigastric pain that does not improve with over‑the‑counter antacids.
• Recurrent ulcer symptoms despite standard ulcer therapy (e.g., proton‑pump inhibitors).
• Unexplained weight loss, chronic diarrhea, or foul‑smelling stools.
• Visible blood in vomit or stool, or a sudden drop in hemoglobin.
• Family history of MEN 1 or known gastrinoma.
• Persistent nausea/vomiting that interferes with nutrition.

If you experience any of these, schedule a primary‑care or gastroenterology appointment without delay.

Diagnosis

Diagnosing ZES involves confirming hypergastrinemia, demonstrating high gastric acid output, and locating the gastrinoma.

1. Laboratory Tests

• Fasting serum gastrin level – Values > 1000 pg/mL are highly suggestive; mildly elevated levels require provocative testing.
• Secretin stimulation test – Increases gastrin > 200 pg/mL in ZES patients but not in other causes.
• Baseline gastric pH – A pH < 2 confirms acid hypersecretion.
• Complete blood count (CBC) and iron studies – Assess for anemia.

2. Imaging Studies

• Endoscopic ultrasound (EUS) – Highly sensitive for small pancreatic or duodenal gastrinomas.
• Multiphasic contrast‑enhanced CT or MRI – Detects primary tumors and metastatic disease.
• Somatostatin receptor scintigraphy (Octreoscan) or Gallium‑68 DOTATATE PET/CT – Gold standard for locating neuroendocrine tumors.
• Upper endoscopy (EGD) – Visualizes ulcerations; biopsies rule out malignancy.

3. Additional Evaluations

• Genetic testing for MEN 1 mutations if family history is suggestive.
• Bone density testing if prolonged hyperparathyroidism is suspected.

Sources: NCCN Neuroendocrine Tumor Guidelines; ACG Clinical Guideline for Peptic Ulcer Disease; CDC.

Treatment Options

Treatment targets two goals: controlling acid hypersecretion and removing or controlling the tumor.

Medical Management (Acid Control)

• High‑dose proton‑pump inhibitors (PPIs) – Omeprazole 40–80 mg daily or equivalent; they are the cornerstone for symptom relief.
• Histamine‑2 receptor antagonists (H2RAs) – May be added for breakthrough symptoms.
• Antacids – For immediate relief, but not a substitute for PPIs.
• Somatostatin analogues (octreotide, lanreotide) – Reduce gastrin secretion and can shrink tumor size, especially in metastatic disease.

Surgical Treatment

• Enucleation or local resection of small (< 2 cm) gastrinomas when feasible.
• Pancreaticoduodenectomy (Whipple procedure) for larger or multiple tumors.
• When disease is metastatic, debulking surgery may improve symptom control.

**Adjuvant therapies** – For unresectable or metastatic gastrinomas:

• Targeted radiotherapy (e.g., peptide‑receptor radionuclide therapy).
• Systemic chemotherapy (streptozocin‑based regimens) in selected cases.
• Interferon‑α for refractory disease.

Lifestyle & Home Measures

• Avoid foods that stimulate acid production (citrus, coffee, alcohol, spicy foods).
• Eat small, frequent meals rather than large meals.
• Maintain a healthy weight to reduce abdominal pressure.
• Stop smoking and limit NSAID use.
• Stay hydrated; replace electrolytes if chronic diarrhea is present.

Prevention Tips

Because gastrinomas are largely sporadic, primary prevention is limited, but the following steps can reduce the risk of complications and may help detect disease earlier:

• Know your family history – If a first‑degree relative has MEN 1 or a gastrinoma, discuss screening with a gastroenterologist.
• Get tested for H. pylori and treat if positive to lower overall ulcer burden.
• Limit chronic use of NSAIDs and avoid high‑dose aspirin unless medically indicated.
• Adhere to prescribed PPI therapy; do not discontinue abruptly without medical guidance.
• Have regular follow‑up endoscopic or imaging studies if you have known ZES, as recurrence can occur.

Emergency Warning Signs

---

© 2026 HealthInfoPlus. Content reviewed by board‑certified gastroenterologists. For personalized medical advice, always consult your healthcare provider.

```